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This study compares three different Enzyme Immuno Assays (EIA’s) ((Immunocard Toxins A&B®, Wampole® C. Difficile tox A/B and Premier TM Toxins A&B) for the detection of Clostridium difficile in neonatal diarrhoea of piglets (0-7 days). Diarrhoeal samples (n=65) from seven different farms in the Netherlands were collected. 44 of these 65 samples were tested simultaneously with three EIA’s. Bacterial culture was performed on all 65 samples.
No significant association was found between the EIA’s and bacterial culture. In total we found 41 of 65 samples positive for Clostridium Difficile with bacterial culture. 15 of these were confirmed by PCR all to be ribotype 078.

Introduction
Clostridium difficile (CD) is the major cause of nosocomial-acquired diarrhoea in European hospitals. CD is a ubiquitous organism that has been recognised as an important emerging pathogen in both humans and animals. In The Netherlands, concerns have been raised as to the increasing prevalence of hyper virulent strains and number of severe and fatal CDI cases. Since 2003, new hyper virulent strains of CD emerged and caused more severe and complicated CD infections with relatively high mortality rates and high epidemic potential in many western countries, including The Netherlands (Kuijper, van den Berg & Debast 2006, Paltansing et al. 2007) Since 2005, an increase in the prevalence of CD PCR ribotype O78  has been noticed in the Netherlands. This strain has also been identified as an important strain in swine and calves (Debast et al. 2009, Goorhuis et al. 2008a, Goorhuis et al. 2008b, Keel et al. 2007, Alvarez-Perez et al. 2009)

Clostridium difficile is a Gram positive, spore forming, anaerobic bacteria that causes Clostridium difficile associated diarrhoea (CDAD). Since 2000, CD has been found as a major pathogen in the cause of neonatal diarrhoea in newborn piglets. The importance of CD as an agent involved in swine enteritis has increased, displacing classical bacterial pathogens (Songer 2004, Songer, Anderson 2006, Yaeger, Funk & Hoffman 2002).There are no accurate estimates of the prevalence in the Netherlands or worldwide, but a recent study from Spain suggests that at least 25% of the piglets from 0 to 7 days are infected (Alvarez-Perez et al. 2009). Affected piglets present with diarrhoea varying from yellow to orange and pasty, slimy to watery.

Knowledge is greatly lacking with respect to the reservoir of pathogenic CD strains involved in human CDI. Research showed that indistinguishable CD strains occur in human and in pig populations. 
Like the hospital isolates, piglet derived CD ribotype O78 contained the genes tcdA and tcdB, were binary toxin positive and had a 39-bp deletion in tcdC (Debast et al. 2009, Goorhuis et al. 2008a). Gaining insight in the onset and possible transmission patterns of CDI from animals to humans, as a potential zoonotic disease, is thus of great public health importance. To obtain more insight it is essential to improve the detection methods for CD in pigs. The diagnostics to detect CD toxins in pigs do not seem to have a high sensitivity (Anderson, Songer 2008, Post, Jost & Songer 2002). 
In the detection of human CDAD, EIA’s are used that detect both toxins A and B. A number of commercial toxin detection kits are available for the detection of CD.(Planche et al. 2008)

Pathogenic strains of CD produce different toxins: toxins A, toxin B and a binary toxin. These toxins are responsible for the damage to the colonic epithelial cells as a result of the disruption of the cytoskeleton of the enterocytes (Knoop, Owens & Crocker 1993). Diagnosis of porcine CDAD includes clinical history, gross and microscopic pathology, bacteriologic culture and detection of toxins A and/or B. Toxin detection is the primary confirmatory diagnostic test used to detect a CD infection. These Enzyme immuno assays (EIA’s) are rapid, sensitive in human stool samples and relative easy to perform. The reference method for detection of CD is cytotoxicity of a faecal sample in cell culture that may be neutralised by antiserum. This test takes 3 days to complete and is very time and work consuming. Besides this some researchers recommend additional culture of the faecal sample (toxigenic culture), to improve sensitivity (Avesani et al. 2005).

Over the past years detection methods for CD developed. The first EIA’s could only detect one toxin; A or B. Nowadays there are test which detect both toxins A and B and by using these test, isolates which produce only one of the two toxins will not be missed. Because the toxin is labile denaturation may occur if material is not stored in a coolbox or refrigerator immediately after collection.

This study compares three different human commercial EIA’s for the detection of CD in newborn piglets with culture and a cytoxicity assay. In order to determine which EIA’s would be the best to identify CD in piglets. Earlier research determined a sensitivity and specificity of 91% and 86% of the Techlab® EIA for the use in pigs (Post, Jost & Songer 2002). The EIA’s used on human stool samples have high sensitivity and a high specificity (Table 1). (Planche et al. 2008) 
EIA’s	Sensitivity	Specificity
Premier ™	0,95 (0,86-0,97)	0,97 (0,95-0,98)










When the prevalence of CD is relatively low (<10%), the positive predictive value of these assays is unacceptably low (Planche et al. 2008). To determine the prevalence of CD in the pig population in The Netherlands we need a reliable and quick test. Besides this it is important for further research to determine the ribotypes of CD current in the Netherlands among the pig population and the susceptibility of these strains to different antimicrobials.








Faecal samples were collected on seven different pig farms throughout the Netherlands. (Figure 1) from piglets with clinical sings of neonatal diarrhoea; varying from pasty, slimy to watery. All the samples were taken from piglets less then 7 days old.
All the farms were coping with diarrhoea problems with neonatal piglets (0-7 days) for a minimum of a year and used a lot of different antibiotics as preventive therapy. The Diarrhoea did not respond to this antibiotic treatment. Mortality was low, although growth was declined. Per litter at least half of the piglets were affected.
The piglets were squeezed in het abdomen in order to obtain fresh faecal samples. Samples were collected in sterile 50 ml tubes (Falcon®) and stored directly in a cool box. After transport they were directly stored in a refrigerator (2-8°C). Within 48 hours the samples were processed. In total we collected 65 samples.

Assays
Samples were tested with three enzyme immuno assays; Immunocard Toxins A&B®, Wampole® C. Difficile tox A/B and Premier TM Toxins A&B.
The cytotoxin Assays was used as a golden standard method for the diagnosis of CDI. 
Besides the cytotoxin assay we used a second reference for the positive samples. We cultured all samples on clostridium specific plates (CLO, CNA and SCS plates). Afterwards CD positive plates were send to the LUMC Leids University Medical Centre (LUMC Reference Laboratory, Leiden, The Netherlands) for further determination by PCR to determine the ribotype.

Cytotoxin Assay 
The tissue culture assay was performed according to a standardized protocol used in the LUMC (Reference Laboratory, Leiden, The Netherlands) using Vero cells. Cells were tested for mycoplasm with a PCR. A suspension of faecal sample was made in MEM 10% Foetal calf serum after centrifugation, the supernatant was filtered through a 1,2 µm filter and a 0,45 µm filter. The cytotoxin assay was performed by testing this filtrate on an 80% confluent monolayer of Vero Cells in a 24 Grainer Well plate. Per faecal sample we tested 3 dilutions; the undiluted filtrate, 1:10 dilution and a 1:100 dilution. The cells were examined both after 24 hours and 48 hours of incubation at 37°C in a 5% CO2 incubator for cell rounding and clumming of cells. Positive results were confirmed by neutralisation with Techlab® C.diffficile toxin A and B polyclonal goat antiserum. 
All assays were performed on the same day for each batch of samples. The samples were stored < 48 hours at 2-8°C before testing.

Culture
Faecal samples were all cultured for presence of CD using CLO and CNA plates (Biomerieux) with ethanol shock pre-treatment. 0,5 ml of faecal samples was mixed with the same amount of ethanol 96%. The mixture was incubated for 60 minutes at room temperature. Thereafter the mixture was inoculated on CNA plates and CLO plates. (Biomerieux). After 48 hours anaerobe incubation at 37°C using closed containers (Oxoid HP) and adding special anaerobe gas packs (BD).
CD colonies were identified by their specific smell (like horse dung), non haemolytic and white, grey and green colour.
All colonies grown on CLO plates were incubated anaerobic for another 48 hours at 37°C on Schadler agar plates (SCS, Biomerieux). Colonies from the CNA plate were inoculated on SCS plates, only if there was no growth on the CLO plate. Grown colonies were gram-stained. Suspected colonies for CD were send to the LUMC (Clostridium Reference Laboratory, Leiden, The Netherlands) for confirmation and PCR ribotyping. 

PCR confirmation
Colonies were genetically examined using a PCR method to determine the presence of gluD gene encoding glutamate dehydrogenase specific for CD (Paltansing et al. 2007). The PCR-confirmed positive CD samples were then PCR ribotyped.

Enzyme Immuno Assay’s:
The whole batch of faecal samples was tested at the same time and within 48 hours after collection with three different EIA’s listed below.

Immunocard Toxins A & B (Meridian, Bioscience, Inc.) is an immuno affinity assay based on a one-strip test for the detection of CD toxins A and B.
It consists of a membrane held in a plastic frame with two sample ports and two reaction ports. The membrane carries immobilized antibodies to toxins A and B. The Enzyme Conjugate Reagent consists of antibodies to toxins A and B coupled to horseradish peroxidise. Faecal samples are diluted with Specimen Diluent and Enzyme Conjugate and the mixture is incubated for 5 minutes. During the incubation, molecules of toxin, if present, are bound to the anti-toxin antibodies of the Conjugate. Following incubation, an aliquot of the mixture is added to each of the two sample ports and the test is incubated for an additional 5 minutes at 20-26 C. During the second incubation the toxin-conjugate complex is separated from particulate matter as the fluid portion of the sample flows through the membrane to the TEST and CONTROL reaction ports. The toxin-conjugate complexes are then captured at the TEST reaction port by immobilized antitoxin in the reaction membrane. (The second of the two reaction ports serves as an internal control.) Both reaction ports are subsequently washed with Wash Reagent to reduce interference by contaminating proteins before Substrate Reagent is added. The reaction ports are incubated for an additional 5 minutes during which time the enzyme conjugate modifies the Substrate Reagent. Reactions are read visually. Development of a blue colour in the TEST reaction port indicates a positive test. In the CONTROL port, the anti-toxin antibodies of the conjugate bind directly to the immobilized toxin. The appearance of blue in the CONTROL reaction port indicates that sample was added, that reagents were active at the time of use and that proper sample migration occurred. (Immunocard Toxins A & B manual)

The Wampole® C. Difficile tox A/B (Techlab. Blacksburg, VA.) is an Enzyme immuno assay detecting toxins A and B of CD. The microwells contain immobilized affinity-purified polyclonal goat antibody against toxins A and B. The detecting antibody is a mixture of toxin A monoclonal mouse antibody and toxin B polyclonal goat antibody, both conjugated to horseradish peroxidise. An aliquot of feces was diluted in the kit diluent. If toxins A and B are present in the specimen, they will bind to the detecting antibody and to the immobilized polyclonal antibody during the incubation phase. Any unbound material is removed during the washing steps. Following the addition of substrate, a colour is detected due to the enzyme-antibody-antigen complexes that form in the presence of toxin. Positive and Negative controls were performed with each series of test specimens.
The microtiter plate was read with a universal micro plate reader (Bio-Tek instruments, Inc.)

PremierTM Toxins A&B (Meridian, Bioscience, Inc.) is an enzyme immunoassay for the direct detection of Clostridium difficile toxin A and toxin B in stool samples. Breakaway microwells are coated with toxin specific monoclonal and polyclonal antibodies.
Diluted specimens and HRP-conjugated anti-toxin A and B polyclonal antibodies are added to microwells. If either toxin is present in the diluted patient samples, HRP-conjugated toxin polyclonal antibodies (specific for both toxins) complexes are formed which remain in the microwells after washing. After a final washing step, a substrate/chromagen (urea peroxide and tetramethylbenzidine) is added to the wells. Any bound conjugate converts
the substrate/chromagen to a blue colour. Addition of acid (Stop Solution) converts the blue to a yellow colour. (Premier TM Toxins A&B manual). The microtiter plate was read with a universal micro plate reader (Bio-Tek instruments, Inc.). Positive and Negative controls were performed with each series of test specimens.

Analysis
The cytotoxicity assay (CA) was not performed on all processed samples because there were problems with the growing and sub culturing of the cell line. It was not possible to read reliable results from the CA. 
We were not able to determine sensitivity, specificity, positive predictive values (PPVs) and negative predictive values (NPV) because we couldn’t compare the outcome of the EIA’s with the golden standard, the Cytotoxicity assay.





Faecal samples from seven farms were analysed. In total we had 65 samples. 
41 samples were found positive by our culture method and gram staining. 15 of those samples were confirmed by the PCR in the LUMC. We are still waiting for the results of the PCR for the other samples. The positive samples were all CD ribotype 078. 

On 44 samples of the 65 samples three different enzyme immuno assays were performed
The PremierTM was 37 times positive and 7 times negative. 
The The Wampole® was 26 times positive and 17 times negative; one time the result was not usable.
The Immunocard® was 24 times positive and 20 times negative. 
In 19 of those 44 samples the EIA’s all had the same result (positive or negative). This is less than half of the samples. In 13 out of 44 samples the results of all the EIA’s associated with the outcome of the bacterial culture and gram staining method. Table 2 gives an overview of these results.

The cytoxicity assay
There were a lot of problems starting and growing the cell line; because of this it was not possible to compare the results from the EIA’s with the outcome of the cytotoxicity assay.
Every time the cells died after putting the supernatant and it’s dilutions on the 24 well plates. After changing a lot of things in the protocol of the cells and testing the cells for mycoplasm the cell line worked.
The main problems that were encountered were
-	the cell culture was kept at a CO2 percentage which was too low because there was a mechanical failure with the stove 
-	There should have been made two passages per week.
-	The PH of the medium was in between 6,5 an 7,5, which was good
-	It’s important to keep the cells wet with medium. It was essential to keep the cell wet at all times and to minimize the time in-between the steps were the cells were without any medium.
-	It is the best to do the experiment one day after making the 24 well plates with 50000 cells/ml suspension. 

Unfortunately there weren’t enough faecal samples stored to repeat the experiment per sample with the cytotoxicity assay. This would also have increased the processing time with more than 48 hours.

Statistics
All the farms that were sampled were found positive for CD 078. In total 41 of the 65 samples were positive for CD with the bacteriologic culture and gram stain. From the limited samples that were taken a prevalence of 63% of CD in neonatal piglets with diarrhoea can be calculated.
 









































































Because there is no significant association between the different EIA’s compared with the bacteriologic culture and gram stain not one EIA can be advised to use either as a diagnostic tool or for screening purposes, at this moment.
	
Discussion
This study compared the outcome of the EIA’s with the bacterial culture method. It is not ideal to demonstrate this association because bacterial culture and gram stain do not have a specificity and sensitivity of 100%.
Recent articles suggest to combine culture with a cytotoxicity assay (Avesani et al. 2005). 
The toxin test tests for toxin; it’s a protein which degrades very quickly. Therefore it is very important that good storage conditions are used and obtained. In this study all precautions were taken and good handling of the specimens was performed but still some posive samples could have been missed using the EIA’s. 
Besides this it is an idea to retest the negative samples with the different EIA’s. A new feacel sample could be taken from the piglet. In human stool samples it is advised to retest a negative sample which is of high clinical suspicion. (Nemat et al. 2009) 

On the farm:
For farmers the biggest problem is to deal with the diarrhoeal problem. In all the farms visited the problem lasted already for more than one year. All sorts of treatments were tried and none of them were effective. In human hospitals a strict protocol is followed when patients are diagnosed with CDAD. It is not within reach to implement measures used in human hospitals within swine producing farms. It is quite impossible to get a farm free of CD when CD is diagnosed. The spores of CD are highly resistant and regular cleaning of the pens is not sufficient to get rid of the spores. Spores survive for months and can persist on hard surfaces for as long as 5 months (Gerding, Muto & Owens 2008) Cleaning with sodium hypochlorite is suggested by Gerding et al. for hospitals. Sodium hypochlorite is a cleaning agent which is sporicidal. In theory it will destroy the spores produced by CD. Its disadvantages are that it is malodorous, corrosive and can cause pitting on equipment over longer term. It may also cause respiratory difficulties. (Gerding, Muto & Owens 2008) For a pig producing unit this may not be the most ideal cleaning solution.
In humans an increase use of fluoroquinolon’s and cephalosporins is recognized as a risk factor. In human outbreaks the isolation in combination with restricting use of fluoroquinolones and cephalosporins appeared to be successful (6 Kuijper,E.J et al., 2006). Hopefully, antibiotic use is minimized in the Dutch swine industry in the future. 

Recommendations for future research
The sampling of pig farms which are coping with unsolved diarrhoeal problems should be preceded. The experiment should be repeated with a good working cell line in order to obtain a real sensitivity and specificity. That way it will be possible to compare the EIA’s with each other and the golden standard; the cytotoxicity assay. It will be possible to determine one EIA which can be used for the detection of CD in pigs. 
For further research it would be interested to test the antibiotic susceptibility on the CD strains we collected and to compare this antibiotic susceptibility with the antibiotic susceptibility of human CD strains.
It is also important to know when the piglets exceed the biggest amount of toxins and when they are the most infective to other piglets. In other words how does the transmission of CD among piglets proceed and what is the best sampling moment in order not to miss any positive piglets. How do the piglets get infected with CD, do they get infected from the spores in the environment or do they get infected by the sow? The spores of CD survive for a long period in the environment, because of this it is of great interest to investigate where these spores are in a pen or on the different units of the farm. You could sample different places in the pig breeding unit and search for spores of CD.

Prevalence of CD should be measured on the farm and in the litter. A surveillance study of CD in the Netherlands should be carried out. And like the Spanish study (Alvarez-Perez et al. 2009)it would be interesting to determine the prevalence in diarrhoeic and non diarrhoeic piglets in the Netherlands.

The question remains whether CD is a zoonosis. To answer this question it is important to answer all the questions listed above and to picture the contact structures of a pig farm. It would also be interesting to identify the differences and similarities between the types 078 found in this study. 
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Tabel 1. Sensitivity and specificity of the three different EIA’s used in humans. {{18 Planche,T. 2008; }}

Figure 1. Locations of  visited pigfarms 

Table 2; results from the EIA’s, bacterial culture and gram stain, Cytotoxicity assay and PCR on faecal samples from farm A up to G. 1 is positive, 0 is negative and -  means no assay was performed. 078 is the ribotype of CD.
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